SK Hynix is walking a tightrope between two very different opportunities. The South Korean chipmaker is scaling back its planned conversion of production lines for the next-generation HBM4 memory, instead pouring resources into conventional DDR5 chips where a supply crunch is driving operating margins to historic highs. At the same time, it has dispatched samples of its new 12-layer HBM4E to major customers and signed a multi-year development pact with Nvidia, locking in its role as a key architectural partner for the chip giant’s upcoming Vera-Rubin platform. And to fund it all, the company is preparing to list on the Nasdaq.
The New York Stock Exchange debut — actually on the Nasdaq — was set in motion Wednesday when SK Hynix filed with the US Securities and Exchange Commission. Trading under the ticker SKHY is slated to begin on July 10, with the company issuing roughly 18 million new shares. The total offering is expected to raise a staggering $29.4 billion, making it one of the largest ADR listings in recent memory.
Analysts at NH Investment & Securities see the move as a deliberate attempt to close the valuation gap with US rival Micron. A Nasdaq listing would lift SK Hynix into the ranks of global AI infrastructure plays and shed its historical image as a regional cyclical stock.
The stock has already priced in much of the optimism. Shares closed at 2,917,000 won on Thursday, just 2.3% below the 52-week high. The year-to-date gain stands at 288%, and the stock trades 55% above its 50-day moving average. Market capitalisation is hovering near one trillion euros.
The production pivot is the most immediate catalyst for those gains. SK Hynix is slowing the retooling of some lines for HBM4, the next-generation high-bandwidth memory, to focus on DDR5 where acute supply shortages are pushing profitability to unprecedented levels. Experts at Daishin Securities believe operating margins in the DDR5 segment could hit 90% this year. The move effectively locks in record profits from the broad server market while minimising risk in the core business.
That is not to say the company is neglecting its AI credentials. In mid-June, it delivered initial samples of the new 12-layer HBM4E to key customers. The architecture reduces thermal resistance by 17%, a critical improvement for dense accelerator clusters. Beyond samples, the multi-year development contract with Nvidia ensures SK Hynix remains a central supplier for Nvidia’s next-generation AI platform.
Should investors sell immediately? Or is it worth buying SK Hynix?
Yet the distance between sampling and volume production remains a pivotal uncertainty. Sending out samples proves technical capability, but it does not confirm price agreements, volume commitments, or timeline. Until those are locked in, a portion of the current valuation rests on anticipation rather than hard evidence.
The bullish case argues that the validation process will run smoothly, reinforcing SK Hynix’s leadership through the next HBM cycle. In that scenario, the DRAM reallocation is seen as disciplined capacity management — protecting margins while HBM4E is still in qualification. The stock’s recent price action supports that reading: it has gained 30% in the past 30 days, with buyers paying higher premiums.
The bears point to the same data to warn of vulnerability. The relative strength index stands at 68.1, and annualised 30-day volatility is 104%. With the stock so far above its mean, even a moderate shift in sentiment could trigger sharp downside. If the market interprets the DRAM shift as evidence that the HBM4 ramp is bumpier than expected, the AI premium could evaporate. TrendForce has emphasised the intensely competitive nature of the HBM4E race, and any signs that competitors are closing the gap would force a recalculation of SK Hynix’s leadership premium.
The Nasdaq proceeds already have a designated use. Most of the $29.4 billion will go into domestic production capacity, with a large chunk earmarked for advanced EUV lithography tools. That investment positions SK Hynix for the next wave of demand — but only if it can first convert samples into confirmed orders and keep the margin protection story intact.
For now, the momentum play holds together. Two conditions must be met to sustain the premium: HBM4E sampling must successfully move into customer qualification, and the capacity allocation between HBM and conventional DRAM must strengthen, not dilute, the AI thesis. Until both are confirmed, SK Hynix remains a stock with strong strategic substance but narrow room for execution errors.
Ad
SK Hynix Stock: Buy or Sell?! New SK Hynix Analysis from June 26 delivers the answer:
The latest SK Hynix figures speak for themselves: Urgent action needed for SK Hynix investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 26.
SK Hynix: Buy or sell? Read more here...
